Gallium-Doped Hydroxyapatite: Shape Transformation and Osteogenesis Activity.
gallium
hydroxyapatite
osteogenesis
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
01 Nov 2023
01 Nov 2023
Historique:
received:
04
09
2023
revised:
11
10
2023
accepted:
27
10
2023
medline:
15
11
2023
pubmed:
14
11
2023
entrez:
14
11
2023
Statut:
epublish
Résumé
In this study, we employed a chemical precipitation method to successfully synthesize nanoparticles of gallium-doped hydroxyapatite (Ga-HAp). The microstructure of Ga-HAp was precisely tailored by modulating the concentration of gallium ions. Our findings unequivocally demonstrate that gallium ions exert a pronounced inhibitory influence on the growth of HAp crystals, and this inhibitory potency exhibits a direct correlation with the concentration of gallium. Furthermore, gallium ions facilitate the metamorphosis of HAp nanoparticles, transitioning them from nanoneedles to nanosheets. It is worth noting, however, that gallium ions exhibit a limited capacity to substitute for calcium ions within the crystal lattice of HAp, with the maximum substitution rate capped at 4.85%. Additionally, gallium plays a pivotal role in constraining the release of ions from HAp, and this behavior remains consistent across samples with varying Ga doping concentrations. Our in vitro experiments confirm that Ga-doped HAp amplifies both the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells.
Identifiants
pubmed: 37959798
pii: molecules28217379
doi: 10.3390/molecules28217379
pmc: PMC10648865
pii:
doi:
Substances chimiques
Durapatite
91D9GV0Z28
Gallium
CH46OC8YV4
Ions
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Scientific Research Foundation of Gannan Medical University
ID : XN202004
Organisme : Scientific Research Foundation of Gannan Medical University
ID : QD202115
Références
Polymers (Basel). 2022 Feb 28;14(5):
pubmed: 35267796
J Mater Chem B. 2014 Aug 7;2(29):4703-4710
pubmed: 32262282
Int J Environ Res Public Health. 2010 May;7(5):2337-61
pubmed: 20623028
Inorg Chem. 2011 Sep 5;50(17):8252-60
pubmed: 21793526
Arch Toxicol. 2013 Jun;87(6):1037-52
pubmed: 22415765
Redox Biol. 2015 Dec;6:260-271
pubmed: 26296072
Best Pract Res Clin Rheumatol. 2020 Jun;34(3):101506
pubmed: 32291204
Sci Adv. 2020 Dec 11;6(50):
pubmed: 33310848
Acta Biomater. 2021 Sep 1;131:555-571
pubmed: 34271171
Bioact Mater. 2022 Jul 21;25:594-614
pubmed: 37056253
Cell Tissue Res. 1998 Apr;292(1):163-71
pubmed: 9506924
Pharmacol Rev. 1998 Dec;50(4):665-82
pubmed: 9860806
Biol Trace Elem Res. 2018 Jun;183(2):270-279
pubmed: 28836172
Biomater Adv. 2022 Sep;140:213051
pubmed: 35914326
ACS Appl Mater Interfaces. 2022 Oct 12;14(40):45156-45166
pubmed: 36170227
Bioact Mater. 2021 Sep 16;10:195-206
pubmed: 34901539
Curr Med Chem. 2021;28(10):2062-2076
pubmed: 32484099
J Biomed Mater Res B Appl Biomater. 2018 Jan;106(1):367-376
pubmed: 28152268
Front Endocrinol (Lausanne). 2023 Mar 22;14:1039490
pubmed: 37033238
Adv Healthc Mater. 2017 Dec;6(23):
pubmed: 29171714
Biomaterials. 2005 Aug;26(23):4847-55
pubmed: 15763264
Calcif Tissue Int. 1989 Aug;45(2):81-7
pubmed: 2550117
Calcif Tissue Int. 1989 Feb;44(2):138-42
pubmed: 2537134
Bone. 2016 May;86:119-30
pubmed: 26946132
J Cell Biochem. 2006 Jan 1;97(1):56-70
pubmed: 16229015
Br J Pharmacol. 2010 Apr;159(8):1681-92
pubmed: 20397300